PADCEV (enfortumab vedotin-ejfv): An Antibody-Drug-Conjugate in Combination with a PDL-1 inhibitor
This event begins in
-
Days
-
Hours
-
Minutes
A zoom link will be available the day of this event.
- November 6, 2025
- 8:00 PM EST
National Cornerstone Corner, 8:00 PM
Program Chairs
Sponsors
This program is not CME accredited.
In addition to the Program's educational offerings, a separate portion involves market research sessions for which a fair market value honorarium will be offered to eligible registrants who choose to participate. Additional details are listed on the registration page and dependent on registrant's designation.
